Pregled bibliografske jedinice broj: 290186
Proteomics in antitumor research
Proteomics in antitumor research // Drug discovery today. Technologies, 3 (2006), 4; 441-449 (recenziran, članak, stručni)
CROSBI ID: 290186 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Proteomics in antitumor research
Autori
Fontana, Simona ; De Leo Giacomo ; Sedić, Mirela ; Kraljević Pavelić, Sandra ; Alessandro, Riccardo
Izvornik
Drug discovery today. Technologies (1740-6749) 3
(2006), 4;
441-449
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
proteomika; tumori; proteinski čipovi; 2DE; masena spektrometrija
(proteomics; cancer; protein arrays; 2-DE; masena spektrometrija)
Sažetak
Proteins are the molecular players of fine-tuned regulatory pathways that underlie the behavior of any cell type. Derangement of this wide protein circuitry has a profound effect on cell life and ultimately contributes to the development of diseases such as cancer. New proteomic technologies are rapidly evolving to define and characterize the nodes of this altered protein network, both inside and outside cancer cells. Hopefully, these technologies will become user-friendly laboratory tools to improve cancer management from early detection to the development of rational and patient-tailored therapeutic strategies.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Napomena
Rad je financiran i iz sredstava s projekta Ministarstva znanosti, obrazovanja i športa "Jezgre-Test" (14M09800 ; voditelj projekta prof. dr. sci. Krešimir Pavelić)
POVEZANOST RADA
Projekti:
098-0982464-2393 - Molekularna obilježja miofibroblasta Dupuytrenove bolesti
Ustanove:
Institut "Ruđer Bošković", Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
